A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 230
- Registration Number
- NCT04983589
- Locations
- 🇺🇸
Martel Eye Medical Group /ID# 231332, Rancho Cordova, California, United States
🇺🇸North Valley Eye Medical Group, Inc. /ID# 231270, Mission Hills, California, United States
🇺🇸Global Research Management /ID# 231300, Glendale, California, United States
CoolSculpting® Elite for Non-Invasive Fat Reduction
- Conditions
- Interventions
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Allergan
- Target Recruit Count
- 110
- Registration Number
- NCT04897867
- Locations
- 🇺🇸
Cosmetic Laser Dermatology /ID# 239110, San Diego, California, United States
🇩🇪Bodenseeklinik /Id# 239155, Lindau, Germany
🇺🇸Cosmetic Laser Dermatology /ID# 239111, San Diego, California, United States
JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Allergan
- Target Recruit Count
- 168
- Registration Number
- NCT04891419
- Locations
- 🇨🇳
China-Japan Friendship Hospital /ID# 241680, Beijing, Beijing, China
🇨🇳Beijing Hospital /ID# 233582, Beijing, Beijing, China
🇨🇳Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 233602, Wuhan, Hubei, China
Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Allergan
- Target Recruit Count
- 3
- Registration Number
- NCT04829747
- Locations
- 🇨🇳
Chinese PLA General Hospital /ID# 227546, Beijing, Beijing, China
🇨🇳The Second Hospital of Shanxi Medical University /ID# 227567, Taiyuan, Shanxi, China
🇨🇳The second Affiliated hospital of Zhejiang University school of Medicine /ID# 227558, Hangzhou, Zhejiang, China
Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 315
- Registration Number
- NCT04740827
- Locations
- 🇺🇸
Allied Physicians - Fort Wayne Neurological Center /ID# 226350, Fort Wayne, Indiana, United States
🇺🇸Clinvest Research LLC /ID# 226273, Springfield, Missouri, United States
🇺🇸FutureSearch Trials of Dallas, LP /ID# 226493, Dallas, Texas, United States
A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 90
- Registration Number
- NCT04687046
- Locations
- 🇨🇳
Hainan Boao Super Hospital /ID# 235968, Qionghai, Hainan, China
Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects
- Conditions
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Allergan
- Target Recruit Count
- 102
- Registration Number
- NCT04655300
- Locations
- 🇨🇳
Eurofins China, Haizhu, Guangzhou, China
18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
- Conditions
- First Posted Date
- 2020-11-30
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 220
- Registration Number
- NCT04647214
- Locations
- 🇺🇸
American Institute of Research /ID# 247820, Los Angeles, California, United States
🇺🇸Stiles Eyecare Excellence /ID# 240376, Overland Park, Kansas, United States
🇺🇸Midwest Vision Research Foundation at Pepose Vision Institute /ID# 240537, Chesterfield, Missouri, United States
Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Allergan
- Target Recruit Count
- 172
- Registration Number
- NCT04631588
- Locations
- 🇺🇸
Skin and Cancer Associates, LLP /ID# 225152, Miami, Florida, United States
🇺🇸Advanced Clinical Research /ID# 225155, Salt Lake City, Utah, United States
🇺🇸Austin Institute for Clinical Research /ID# 225154, Pflugerville, Texas, United States
Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
- Conditions
- Interventions
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 64
- Registration Number
- NCT04609020
- Locations
- 🇧🇷
Hospital do Servidor Publico Municipal - Sao Paulo /ID# 239165, Niteroi, Rio De Janeiro, Brazil
🇧🇷Hospital Regional da Asa Norte - Brasilia /ID# 239161, Brasilia, Brazil
🇧🇷Universidade de Sao Paulo - Sao Paulo /ID# 239163, Rio de Janeiro, Brazil